Supplementary tables (1).docx (37.4 kB)
siRNA-Based Approach for Castration-Resistant Prostate Cancer Therapy Targeting Androgen Receptor Signaling Pathway - Supplementary material
dataset
posted on 2023-10-12, 09:37 authored by Yanling Yu, Dimitri Papukashvili, Ruimin Ren, Nino Rcheulishvili, Shunping Feng, Wenqi Bai, Huanhu Zhang, Yanfeng Xi, Xiaoqing Lu, Nianzeng XingSupplementary Table 1. The major characteristics of CSPC and CRPC. CSPC, Castration-Sensitive Prostate Cancer; CRPC, Castration-Resistant Prostate Cancer.
Supplementary Table 2. Interventional clinical trials of siRNA use for cancer. Search criteria: Cancer, siRNA. (Accessed in December 2022, sorted from the newest to the oldest start dates). U.S., United States; U.K., United Kingdom.
